Bone Cancer (Malignant Bone Neoplasm) C&P Exam Prep

Bone Scan (Scintigraphy)

What it measures: Extent of bone involvement, presence of metastatic lesions, and disease activity throughout the skeletal system.

What to expect: Review of existing bone scan imaging; examiner will note date of test and results. Bring copies of any recent bone scans to the exam.

Pain considerations: Bone scan results often correlate with pain locations; be prepared to describe bone pain at each site identified on imaging.

MRI (Magnetic Resonance Imaging)

What it measures: Soft tissue involvement, tumor size and extent, marrow infiltration, and nerve or vascular involvement by the neoplasm.

What to expect: Examiner reviews existing MRI reports. Bring printed or digital copies of all relevant MRI reports with dates.

Pain considerations: MRI findings of marrow edema or cortical destruction correlate with severe bone pain; describe pain severity at those specific anatomical sites.

X-Ray (Plain Radiograph)

What it measures: Bone destruction, pathologic fractures, periosteal reaction, calcification, and structural integrity of affected bones.

What to expect: Examiner reviews existing X-ray reports. Lytic or blastic lesions, pathologic fractures, and post-surgical hardware will be noted.

Pain considerations: X-ray evidence of bone destruction often underrepresents pain severity; verbally describe pain intensity even if imaging appears improved.

Bone Biopsy and/or Culture

What it measures: Histological confirmation of malignancy type (e.g., osteosarcoma, chondrosarcoma, Ewing sarcoma, metastatic carcinoma), grade, and extent.

What to expect: Examiner reviews biopsy pathology reports. This is the definitive diagnostic confirmation of malignancy.

Pain considerations: Biopsy sites may themselves be a source of residual pain; mention this if applicable.

Range of Motion (ROM) Assessment

What it measures: Functional limitation of joints and limbs adjacent to or affected by the malignant bone neoplasm or its treatment (surgery, radiation).

What to expect: Examiner will measure active and passive ROM of affected joints using a goniometer. Weight-bearing and non-weight-bearing assessments may be performed per Correia requirements. DeLuca factors (pain, fatigue, weakness, incoordination, flare-ups, repetitive use) must be considered.

Pain considerations: Pain with motion should be described in terms of location, quality, severity (0-10 scale), and whether it stops you from completing the motion. Report pain at rest, with movement, and after activity.

100%

Active malignant neoplasm of bone. Under 38 CFR 4.71a DC 5012 and general VA policy (38 CFR 4.29 / 4.30), an active malignancy warrants a 100% rating while the cancer is active and for a period following treatment completion (typically a minimum of six months after the cessation of surgical, radiation, or antineoplastic chemotherapy treatment). After that period, the rating is based on documented residuals.

From 38 CFR: 38 CFR 4.29 provides for a 100% rating for a period of six months following the cessation of surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedures. After the six-month period, the rating is based on residuals. 38 CFR 4.30 addresses disability from surgery or treatment that is more disabling than the condition itself during convalescence.

100%

Post-treatment period (38 CFR 4.29): 100% rating is maintained for a minimum of six months following the cessation of surgical, X-ray, antineoplastic chemotherapy, or other therapeutic treatment for malignant neoplasm. During this period, even if the cancer is technically in remission, the 100% rating applies.

From 38 CFR: 38 CFR 4.29: A 100% evaluation will be assigned from the date of onset of the incapacitating episode or from the date of hospital admission for treatment, continuing for a period of six months from the date the treatment was discontinued, at which time the appropriate disability rating will be determined by mandatory VA examination.

0%

Post-treatment residual evaluation: After the mandatory six-month post-treatment period (or longer if treatment is ongoing), the rating is based on documented residuals of the malignancy and/or treatment. Residuals are rated under the most appropriate diagnostic code for the resulting condition (e.g., limited motion of joint, amputation, nerve damage, lymphedema). A 0% (non-compensable) rating is assigned only if residuals are present but do not meet the threshold for a compensable rating under the applicable code. No rating below 10% should be assigned if any compensable residual exists.

From 38 CFR: After the six-month post-treatment evaluation period, VA must rate the veteran based on the actual residuals present. If no compensable residuals exist, a 0% rating may apply, but service connection should still be established to protect future claims.

Bone Pain (Primary Symptom)

How to describe it: Describe the location of bone pain using anatomical terms (e.g., 'deep aching pain in my right femur,' 'sharp stabbing pain at the site of my tumor in my left tibia'). Rate pain on a 0-10 scale. Describe pain at rest, with movement, at night, and after activity. Note whether pain wakes you from sleep.

Example: On my worst days, the pain in my right femur is a 9/10 constant aching that radiates down to my knee. I cannot put any weight on the leg, I cannot sleep through the night, and I require narcotic pain medication every 4-6 hours just to get out of bed. I cannot walk more than 10 feet without stopping due to pain.

Examiner listens for: Severity and quality of pain, pain at rest vs. activity, nocturnal pain (hallmark of malignant bone pain), pain limiting weight-bearing, pain requiring prescription analgesics, pain pattern consistent with tumor location on imaging.

Avoid: Do not say 'the pain is manageable' without qualifying that it is only manageable WITH medication. Do not say 'it's not that bad today' - the examiner rates your overall condition, not just how you feel at that moment. Report your typical and worst-day experience.

Functional Limitation and Mobility

How to describe it: Describe specific activities you can no longer do or can only do with difficulty or pain: walking distances, climbing stairs, lifting, carrying, bending, sitting or standing for extended periods. Quantify limitations (e.g., 'I can only walk one block before I must stop,' 'I cannot climb stairs without a railing and must go one step at a time').

Example: On my worst days I am entirely bed-bound. I cannot dress myself without assistance. I cannot walk to the bathroom without my walker, and even then the pain is an 8/10. I cannot drive. I have not been able to work since my diagnosis.

Examiner listens for: Impact on activities of daily living (ADLs), ability to ambulate, need for assistive devices, limitation of affected extremities, inability to perform occupational duties, dependence on others for care.

Avoid: Do not minimize your mobility limitations by demonstrating abilities during the exam that you cannot sustain. If the examiner sees you walk into the room without a cane but you normally require one, clarify that you brought it but were trying not to seem dramatic. Always bring and use your actual assistive devices.

Treatment Side Effects and Toxicities

How to describe it: Describe specific side effects from chemotherapy (nausea, vomiting, fatigue, peripheral neuropathy, hair loss, immunosuppression, infections), radiation (local tissue damage, fibrosis, radiation necrosis, skin changes), or surgery (wound complications, functional loss, phantom limb pain if amputation occurred).

Example: During my chemotherapy cycles, I was bedridden for 5-7 days after each infusion. I lost 25 pounds, had severe peripheral neuropathy in both hands and feet making it impossible to button my shirt or walk without stumbling, and required hospitalization twice for febrile neutropenia. Even now that treatment is complete, the neuropathy in my feet has not resolved and I fall frequently.

Examiner listens for: Specific treatment modalities received, toxicity grade, lasting versus resolved side effects, hospitalizations related to treatment, impact on function during and after treatment, treatment dates relative to the six-month post-treatment rating clock.

Avoid: Do not omit treatment side effects because you think they are 'expected' or 'temporary.' All treatment-related impairments are relevant to the rating. Document every hospitalization, every ER visit, and every dose reduction or treatment delay caused by side effects.

Pathologic Fractures and Structural Complications

How to describe it: If you have had pathologic fractures (fractures caused by the tumor weakening the bone rather than by trauma), describe the location, date, how it was discovered, treatment (surgery, casting, radiation), and whether it healed completely. Describe any ongoing instability, deformity, or pain at the fracture site.

Example: My right humerus fractured spontaneously while I was simply reaching for a glass of water - no fall, no trauma. I was hospitalized, had surgery with an intramedullary rod placed, and still have significant pain and weakness in that arm 18 months later. I cannot lift more than 2 pounds with that arm and cannot raise it above shoulder height.

Examiner listens for: Pathologic fracture history, surgical intervention required, completeness of healing on imaging, residual deformity or instability, functional loss attributable to the fracture, evidence of non-union or malunion.

Avoid: Do not fail to mention pathologic fractures. They are a major complication that significantly affects rating. Even if the fracture 'healed,' residual pain and weakness are ratable residuals.

Fatigue and Systemic Symptoms (DeLuca Factor)

How to describe it: Describe cancer-related fatigue as distinct from normal tiredness: unrelenting exhaustion that is not relieved by rest, inability to complete tasks you start, need to rest multiple times during simple activities. Note fatigue from both the cancer itself and from treatment.

Example: On my worst days, I wake up exhausted after 10 hours of sleep. I can be showered and dressed by 9am and then need to lie down for 2 hours. I cannot cook a meal, do laundry, or go to a medical appointment on the same day. The fatigue is separate from the pain - even when pain is controlled, I am simply too exhausted to function.

Examiner listens for: Whether fatigue limits the veteran's ability to perform repetitive use tasks (DeLuca factor), how quickly fatigue sets in with activity, whether fatigue is improving or worsening, cancer-related fatigue versus treatment-related fatigue.

Avoid: Do not say 'I get tired sometimes.' Quantify: how many hours per day can you be active? How many rest periods do you need? Can you work a full day? Can you complete a single errand without resting?

Flare-Ups (DeLuca Factor)

How to describe it: Describe episodes when your symptoms are significantly worse than usual. Include frequency (how often do flare-ups occur?), duration (how long do they last?), severity during flare-ups (pain score, mobility loss), and what triggers them (activity, weather, stress, tumor progression).

Example: I have flare-ups of severe bone pain approximately 2-3 times per week that last 4-8 hours each. During these episodes my pain goes from a baseline of 5/10 to a 9-10/10. I cannot walk, I vomit from the pain, and I require breakthrough narcotic medication. These flare-ups have sent me to the ER twice in the last year.

Examiner listens for: Frequency and duration of flare-ups, severity during flare-ups compared to baseline, triggers for flare-ups, whether flare-ups result in emergency care or hospitalization, impact on the veteran's ability to plan activities or work.

Avoid: Do not assume flare-ups are irrelevant because you are not experiencing one at the time of the exam. The examiner must rate your overall condition including flare-up frequency and severity. State explicitly: 'Right now I am having a relatively better day. Let me describe what a bad day looks like.'

Remission Status and Fear of Recurrence

How to describe it: If your cancer is in remission, clearly state when remission was confirmed, what monitoring is ongoing (follow-up scans, labs, oncology appointments), and whether you have any residual symptoms from the cancer or its treatment. Also note any psychological impact such as cancer-related anxiety.

Example: My cancer has been in remission for 14 months, but I remain under active oncology surveillance with bone scans every three months. I still have daily pain at the surgical site rated 4-5/10, persistent peripheral neuropathy in both feet that causes me to fall, and I am unable to return to my pre-cancer occupation as a construction worker due to bone fragility and balance problems.

Examiner listens for: Date of remission confirmation, ongoing monitoring regimen, residual symptoms post-remission, whether treatment-related disabilities persist, and occupational or social functioning after remission.

Avoid: Do not say 'I am in remission so I am fine.' Remission does not mean no disability. All residuals of the cancer and its treatment remain ratable. Clearly document every persistent symptom even after remission.